Insider Transactions in Q2 2024 at Bicycle Therapeutics PLC (BCYC)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2024
|
Baker Bros. Advisors LP |
BUY
Conversion of derivative security
|
Indirect |
2,382,784
+20.07%
|
-
|
|
Apr 18
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
24,000
+1.09%
|
-
|
|
Apr 11
2024
|
Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF |
SELL
Open market or private sale
|
Direct |
257
-1.11%
|
$5,654
$22.49 P/Share
|
|
Apr 03
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
152
-0.65%
|
$3,496
$23.81 P/Share
|
|
Apr 03
2024
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
790
-1.24%
|
$18,170
$23.81 P/Share
|
|
Apr 03
2024
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
955
-1.96%
|
$21,965
$23.81 P/Share
|
|
Apr 03
2024
|
Alistair Milnes CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
955
-1.3%
|
$21,965
$23.81 P/Share
|
|
Apr 03
2024
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
955
-1.0%
|
$21,965
$23.81 P/Share
|
|
Apr 03
2024
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,158
-0.81%
|
$72,634
$23.81 P/Share
|